{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:18:59Z","timestamp":1776269939687,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ejphar.2007.11.078","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T09:49:21Z","timestamp":1205401761000},"page":"130-136","source":"Crossref","is-referenced-by-count":38,"title":["Olanzapine-induced weight gain: Chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution"],"prefix":"10.1016","volume":"585","author":[{"given":"Esther M.","family":"van der Zwaal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieneke C.M.","family":"Luijendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger A.H.","family":"Adan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E.","family":"la Fleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.11.078_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","article-title":"Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?","volume":"29","author":"Aichhorn","year":"2006","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2007.11.078_bib2","first-page":"353","article-title":"Weight gain associated with conventional and newer antipsychotics: a meta-analysis","volume":"36","author":"Allison","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2007.11.078_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejphar.2007.11.078_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1999.tb10908.x","article-title":"Body weight gain induced by antipsychotic drugs: mechanisms and management","volume":"100","author":"Baptista","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2007.11.078_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(95)00033-B","article-title":"Food reward: brain substrates of wanting and liking","volume":"20","author":"Berridge","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2007.11.078_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.078_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine \u2014 pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2007.11.078_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-4347(95)00061-M","article-title":"Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection","volume":"668","author":"Catlow","year":"1995","journal-title":"J. Chromatogr., B Biomed. Appl."},{"key":"10.1016\/j.ejphar.2007.11.078_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0731-7085(95)01651-1","article-title":"Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection","volume":"14","author":"Chiu","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2007.11.078_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-1781(01)00234-7","article-title":"Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate","volume":"101","author":"Fontaine","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2007.11.078_bib11","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1373\/clinchem.2003.022517","article-title":"Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection","volume":"49","author":"Gervasini","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2007.11.078_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1056-8719(03)00058-3","article-title":"An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies","volume":"49","author":"Gunaratna","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2007.11.078_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2007.11.078_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.11.078_bib15","first-page":"81","article-title":"Disposition and biotransformation of the antipsychotic agent olanzapine in humans","volume":"25","author":"Kassahun","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2007.11.078_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug\u2013drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.11.078_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis","volume":"361","author":"Leucht","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.11.078_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2004.09.012","article-title":"Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats","volume":"75","author":"Li","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2007.11.078_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004714-200110000-00008","article-title":"Drug glucuronidation in clinical psychopharmacology","volume":"21","author":"Liston","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2007.11.078_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tips.2006.03.008","article-title":"The hypothalamic H-1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity","volume":"27","author":"Masaki","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.11.078_bib21","doi-asserted-by":"crossref","first-page":"13591","DOI":"10.1073\/pnas.96.24.13591","article-title":"Cognition, schizophrenia, and the atypical antipsychotic drugs","volume":"96","author":"Meltzer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.11.078_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-200103000-00001","article-title":"Atypical antipsychotics and hyperglycaemia","volume":"16","author":"Mir","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2007.11.078_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(98)00205-9","article-title":"Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs","volume":"714","author":"Olesen","year":"1998","journal-title":"J. Chromatogr., B Biomed. Sci. Appl."},{"key":"10.1016\/j.ejphar.2007.11.078_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","article-title":"The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes","volume":"199","author":"Parkinson","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.11.078_bib25","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(02)08913-4","article-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism","volume":"359","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.11.078_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","article-title":"Second-generation antipsychotic agents in the treatment of acute mania \u2014 a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Scherk","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.078_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2007.11.078_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00213-005-2198-2","article-title":"Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder","volume":"181","author":"Seager","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.11.078_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.11.078_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.10.023","article-title":"Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats","volume":"57","author":"Turrone","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.078_bib31","first-page":"608","article-title":"[Sex-difference on flutamide metabolism in rat liver microsomal cytochrome P450 1A2]","volume":"37","author":"Wang","year":"2002","journal-title":"Yao Xue. Xue. Bao."},{"key":"10.1016\/j.ejphar.2007.11.078_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2007.11.078_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.jcp.0000185427.08268.db","article-title":"Effects of age and sex on olanzapine plasma concentrations","volume":"25","author":"Weiss","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2007.11.078_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.078_bib35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4088\/JCP.v63n1002","article-title":"The effects of novel antipsychotics on glucose and lipid levels","volume":"63","author":"Wirshing","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.11.078_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/DMR-100101905","article-title":"Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience","volume":"31","author":"Wrighton","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2007.11.078_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35065604","article-title":"Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean","volume":"410","author":"Yamada","year":"2001","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T21:26:07Z","timestamp":1546205167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908002203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0014299908002203"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.078","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}